EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action

Irina Chernyshova iD, Inna Vasil'eva iD, Nina Moor, Nikita Ivanisenko, Mikhail Kutuzov iD, Tatyana Abramova iD, Alexandra Zakharenko, Olga Lavrik iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Irina Chernyshova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, Poly(ADP-ribose) Polymerase Inhibitors, Nucleosides, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation, the Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2) play a key role in DNA repair. As major sensors of DNA damage, they are activated to produce poly(ADP-ribose). PARP1/PARP2 inhibitors have emerged as effective drugs for the treatment of cancers with BRCA deficiencies. Here, we explored aminomethylmorpholino and aminomethylmorpholino glycine nucleosides as inhibitors of PARP1 and PARP2, using different enzymatic assays. The compounds bearing thymine or 5-Br(I)-uracil bases displayed the highest inhibition potency, with all of them being more selective toward PARP1. Interaction of the inhibitors with the NAD+ binding cavity of PARP1 (PARP2) suggested by the mixed-type inhibition was demonstrated by molecular docking and the RoseTTAFold All-Atom AI-model. The best PARP1 inhibitors characterized by the inhibition constants in the range of 12–15 µM potentiate the cytotoxicity of hydrogen peroxide by displaying strong synergism. The inhibitors revealed no impact on PARP1/PARP2 affinity for DNA, while they reduced the dissociation rate of the enzyme–DNA complex upon the autopoly(ADP-ribosyl)ation reaction, thus providing evidence that their mechanism of action for PARP trapping is due primarily to catalytic inhibition. The most active compounds were shown to retain selectivity toward PARP1, despite the reduced inhibition potency in the presence of histone PARylation factor 1 (HPF1) capable of regulating PARP1/PARP2 catalytic activity and ADP-ribosylation reaction specificity. The inhibitors obtained seem to be promising for further research as potential drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsNucleosidesMolecular Docking SimulationHumansPoly(ADP-ribose) PolymerasesModels, Molecular

Stichwörter der Autor:innen

PARP trapping on DNA damagePARP1PARP2enzyme inhibitioninhibitor design

Substanzen

Poly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPARP2 protein, humanNucleosidesPARP1 protein, humanPoly(ADP-ribose) Polymerases

Autor:innen und Institutionen

  • Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
  • Federal Research Centre Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
  • AIRI, 123112 Moscow, Russia.

ORCID-Profile: Irina Chernyshova, Inna Vasil'eva, Mikhail Kutuzov, Tatyana Abramova, Olga Lavrik

Förderung

  • Ministry of Science and Higher Education of the Russian Federation
  • the Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Chernyshova, I., Vasil'eva, I., Moor, N., Ivanisenko, N., Kutuzov, M., Abramova, T., Zakharenko, A., & Lavrik, O. (2024). Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312526

Vancouver

Chernyshova I, Vasil'eva I, Moor N, Ivanisenko N, Kutuzov M, Abramova T, et al. Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312526

BibTeX
@article{Chernyshova2024,
  author = {Chernyshova, Irina and Vasil'eva, Inna and Moor, Nina and Ivanisenko, Nikita and Kutuzov, Mikhail and Abramova, Tatyana and Zakharenko, Alexandra and Lavrik, Olga},
  title = {Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312526}
}
Kostenlos starten →